nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Tocainide—SCN11A—melanoma	0.0239	0.683	CrCbGaD
Prilocaine—Paralysis—Vemurafenib—melanoma	0.0136	0.0449	CcSEcCtD
Prilocaine—Hyperacusis—Temozolomide—melanoma	0.013	0.0428	CcSEcCtD
Prilocaine—Trauma—Bleomycin—melanoma	0.012	0.0397	CcSEcCtD
Prilocaine—Tocainide—SCN10A—melanoma	0.00901	0.257	CrCbGaD
Prilocaine—Neurotoxicity—Docetaxel—melanoma	0.0083	0.0273	CcSEcCtD
Prilocaine—Extravasation—Bleomycin—melanoma	0.00657	0.0217	CcSEcCtD
Prilocaine—Extravasation—Dactinomycin—melanoma	0.00613	0.0202	CcSEcCtD
Prilocaine—Extravasation—Carmustine—melanoma	0.00574	0.0189	CcSEcCtD
Prilocaine—Neuropathy peripheral—Vemurafenib—melanoma	0.00519	0.0171	CcSEcCtD
Prilocaine—Respiratory failure—Temozolomide—melanoma	0.00493	0.0162	CcSEcCtD
Prilocaine—Depressed level of consciousness—Carmustine—melanoma	0.00483	0.0159	CcSEcCtD
Prilocaine—Neuropathy—Carmustine—melanoma	0.0047	0.0155	CcSEcCtD
Prilocaine—Depressed level of consciousness—Temozolomide—melanoma	0.00467	0.0154	CcSEcCtD
Prilocaine—Disorientation—Bleomycin—melanoma	0.00465	0.0153	CcSEcCtD
Prilocaine—Neuropathy—Temozolomide—melanoma	0.00454	0.015	CcSEcCtD
Prilocaine—Injury—Bleomycin—melanoma	0.00453	0.0149	CcSEcCtD
Prilocaine—Dermatitis atopic—Docetaxel—melanoma	0.00435	0.0143	CcSEcCtD
Prilocaine—Swelling—Carmustine—melanoma	0.00412	0.0136	CcSEcCtD
Prilocaine—Injury—Carmustine—melanoma	0.00395	0.013	CcSEcCtD
Prilocaine—Extravasation—Docetaxel—melanoma	0.00369	0.0122	CcSEcCtD
Prilocaine—Diplopia—Carmustine—melanoma	0.00363	0.012	CcSEcCtD
Prilocaine—Bronchospasm—Bleomycin—melanoma	0.00354	0.0117	CcSEcCtD
Prilocaine—Diplopia—Temozolomide—melanoma	0.00351	0.0116	CcSEcCtD
Prilocaine—Anaphylactic shock—Vemurafenib—melanoma	0.00338	0.0111	CcSEcCtD
Prilocaine—Nervous system disorder—Vemurafenib—melanoma	0.00331	0.0109	CcSEcCtD
Prilocaine—Respiratory failure—Docetaxel—melanoma	0.00328	0.0108	CcSEcCtD
Prilocaine—Hypotension—Vemurafenib—melanoma	0.00316	0.0104	CcSEcCtD
Prilocaine—Neuropathy—Docetaxel—melanoma	0.00302	0.00995	CcSEcCtD
Prilocaine—Lightheadedness—Docetaxel—melanoma	0.00288	0.00949	CcSEcCtD
Prilocaine—Hypoaesthesia—Bleomycin—melanoma	0.00287	0.00944	CcSEcCtD
Prilocaine—Neuropathy peripheral—Carmustine—melanoma	0.00274	0.00905	CcSEcCtD
Prilocaine—Neuropathy peripheral—Temozolomide—melanoma	0.00265	0.00874	CcSEcCtD
Prilocaine—Swelling—Docetaxel—melanoma	0.00265	0.00872	CcSEcCtD
Prilocaine—Hypoaesthesia—Carmustine—melanoma	0.0025	0.00824	CcSEcCtD
Prilocaine—Hypersensitivity—Vemurafenib—melanoma	0.00249	0.0082	CcSEcCtD
Prilocaine—Asthenia—Vemurafenib—melanoma	0.00242	0.00799	CcSEcCtD
Prilocaine—Hypoaesthesia—Temozolomide—melanoma	0.00242	0.00797	CcSEcCtD
Prilocaine—Cardiac failure—Docetaxel—melanoma	0.00239	0.00789	CcSEcCtD
Prilocaine—Anaemia—Bleomycin—melanoma	0.00232	0.00764	CcSEcCtD
Prilocaine—Tinnitus—Temozolomide—melanoma	0.00227	0.00747	CcSEcCtD
Prilocaine—Arrhythmia—Carmustine—melanoma	0.00225	0.0074	CcSEcCtD
Prilocaine—Dizziness—Vemurafenib—melanoma	0.00223	0.00736	CcSEcCtD
Prilocaine—Anaemia—Dactinomycin—melanoma	0.00216	0.00712	CcSEcCtD
Prilocaine—Vomiting—Vemurafenib—melanoma	0.00215	0.00708	CcSEcCtD
Prilocaine—Tocainide—ALB—melanoma	0.00207	0.0592	CrCbGaD
Prilocaine—Confusional state—Bleomycin—melanoma	0.00206	0.0068	CcSEcCtD
Prilocaine—Vision blurred—Carmustine—melanoma	0.00206	0.0068	CcSEcCtD
Prilocaine—Tremor—Carmustine—melanoma	0.00205	0.00676	CcSEcCtD
Prilocaine—Oedema—Bleomycin—melanoma	0.00205	0.00674	CcSEcCtD
Prilocaine—Anaphylactic shock—Bleomycin—melanoma	0.00205	0.00674	CcSEcCtD
Prilocaine—Anaemia—Carmustine—melanoma	0.00202	0.00667	CcSEcCtD
Prilocaine—Nausea—Vemurafenib—melanoma	0.00201	0.00661	CcSEcCtD
Prilocaine—Vision blurred—Temozolomide—melanoma	0.00199	0.00657	CcSEcCtD
Prilocaine—Bronchospasm—Docetaxel—melanoma	0.00199	0.00654	CcSEcCtD
Prilocaine—Tremor—Temozolomide—melanoma	0.00198	0.00653	CcSEcCtD
Prilocaine—Anaemia—Temozolomide—melanoma	0.00195	0.00644	CcSEcCtD
Prilocaine—Hypotension—Bleomycin—melanoma	0.00191	0.0063	CcSEcCtD
Prilocaine—Oedema—Dactinomycin—melanoma	0.00191	0.00629	CcSEcCtD
Prilocaine—Hypertension—Carmustine—melanoma	0.00189	0.00623	CcSEcCtD
Prilocaine—Anxiety—Carmustine—melanoma	0.00186	0.00612	CcSEcCtD
Prilocaine—Paraesthesia—Bleomycin—melanoma	0.00184	0.00606	CcSEcCtD
Prilocaine—Hypertension—Temozolomide—melanoma	0.00183	0.00602	CcSEcCtD
Prilocaine—Confusional state—Carmustine—melanoma	0.0018	0.00594	CcSEcCtD
Prilocaine—Anxiety—Temozolomide—melanoma	0.00179	0.00591	CcSEcCtD
Prilocaine—Oedema—Carmustine—melanoma	0.00179	0.00589	CcSEcCtD
Prilocaine—Neuropathy peripheral—Docetaxel—melanoma	0.00176	0.00581	CcSEcCtD
Prilocaine—Pain—Bleomycin—melanoma	0.00175	0.00577	CcSEcCtD
Prilocaine—Confusional state—Temozolomide—melanoma	0.00174	0.00574	CcSEcCtD
Prilocaine—Oedema—Temozolomide—melanoma	0.00173	0.00569	CcSEcCtD
Prilocaine—Anaphylactic shock—Temozolomide—melanoma	0.00173	0.00569	CcSEcCtD
Prilocaine—Nervous system disorder—Temozolomide—melanoma	0.00169	0.00558	CcSEcCtD
Prilocaine—Feeling abnormal—Bleomycin—melanoma	0.00169	0.00556	CcSEcCtD
Prilocaine—Hypotension—Carmustine—melanoma	0.00167	0.0055	CcSEcCtD
Prilocaine—Hyperhidrosis—Temozolomide—melanoma	0.00167	0.0055	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—MAP2K1—melanoma	0.00164	0.00248	CbGpPWpGaD
Prilocaine—Pain—Dactinomycin—melanoma	0.00163	0.00538	CcSEcCtD
Prilocaine—Urticaria—Bleomycin—melanoma	0.00163	0.00536	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—RAC2—melanoma	0.00161	0.00244	CbGpPWpGaD
Prilocaine—Hypoaesthesia—Docetaxel—melanoma	0.00161	0.0053	CcSEcCtD
Prilocaine—Paraesthesia—Carmustine—melanoma	0.0016	0.00529	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—ITGB3—melanoma	0.0016	0.00242	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NODAL—melanoma	0.0016	0.00242	CbGpPWpGaD
Prilocaine—Somnolence—Carmustine—melanoma	0.00159	0.00523	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—MAP2K1—melanoma	0.00158	0.00239	CbGpPWpGaD
Prilocaine—Feeling abnormal—Dactinomycin—melanoma	0.00157	0.00518	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—MAP2K2—melanoma	0.00157	0.00237	CbGpPWpGaD
Prilocaine—Paraesthesia—Temozolomide—melanoma	0.00155	0.00511	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NODAL—melanoma	0.00154	0.00233	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—DCX—melanoma	0.00154	0.00233	CbGpPWpGaD
Prilocaine—Somnolence—Temozolomide—melanoma	0.00153	0.00506	CcSEcCtD
Prilocaine—Pain—Carmustine—melanoma	0.00153	0.00503	CcSEcCtD
Prilocaine—Hypersensitivity—Bleomycin—melanoma	0.00151	0.00497	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—RAC1—melanoma	0.00149	0.00225	CbGpPWpGaD
Prilocaine—Pain—Temozolomide—melanoma	0.00148	0.00486	CcSEcCtD
Prilocaine—Feeling abnormal—Carmustine—melanoma	0.00147	0.00485	CcSEcCtD
Prilocaine—Asthenia—Bleomycin—melanoma	0.00147	0.00484	CcSEcCtD
Prilocaine—Arrhythmia—Docetaxel—melanoma	0.00144	0.00476	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—EPHA2—melanoma	0.00143	0.00217	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PAX4—melanoma	0.00143	0.00217	CbGpPWpGaD
Prilocaine—Feeling abnormal—Temozolomide—melanoma	0.00142	0.00469	CcSEcCtD
Prilocaine—Hypersensitivity—Dactinomycin—melanoma	0.00141	0.00463	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—RHOB—melanoma	0.00139	0.0021	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—DCC—melanoma	0.00137	0.00208	CbGpPWpGaD
Prilocaine—Urticaria—Temozolomide—melanoma	0.00137	0.00452	CcSEcCtD
Prilocaine—Asthenia—Dactinomycin—melanoma	0.00137	0.00451	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—RHOB—melanoma	0.00133	0.00201	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—DCC—melanoma	0.00132	0.00199	CbGpPWpGaD
Prilocaine—Hypersensitivity—Carmustine—melanoma	0.00132	0.00434	CcSEcCtD
Prilocaine—Vomiting—Bleomycin—melanoma	0.0013	0.00429	CcSEcCtD
Prilocaine—Anaemia—Docetaxel—melanoma	0.0013	0.00428	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—RHOB—melanoma	0.00129	0.00194	CbGpPWpGaD
Prilocaine—Asthenia—Carmustine—melanoma	0.00128	0.00422	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—SCN10A—melanoma	0.00128	0.00193	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—DCC—melanoma	0.00127	0.00192	CbGpPWpGaD
Prilocaine—Hypersensitivity—Temozolomide—melanoma	0.00127	0.00419	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—RHOB—melanoma	0.00127	0.00191	CbGpPWpGaD
Prilocaine—Syncope—Docetaxel—melanoma	0.00126	0.00416	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—DCC—melanoma	0.00125	0.00189	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—RAC2—melanoma	0.00124	0.00188	CbGpPWpGaD
Prilocaine—Asthenia—Temozolomide—melanoma	0.00124	0.00408	CcSEcCtD
Prilocaine—Loss of consciousness—Docetaxel—melanoma	0.00124	0.00407	CcSEcCtD
Prilocaine—Nausea—Bleomycin—melanoma	0.00122	0.00401	CcSEcCtD
Prilocaine—Hypertension—Docetaxel—melanoma	0.00121	0.004	CcSEcCtD
Prilocaine—Vomiting—Dactinomycin—melanoma	0.00121	0.004	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—RAC2—melanoma	0.00119	0.00181	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CDH2—melanoma	0.00119	0.0018	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—ITGAV—melanoma	0.00118	0.00179	CbGpPWpGaD
Prilocaine—Dizziness—Carmustine—melanoma	0.00118	0.00389	CcSEcCtD
Prilocaine—Confusional state—Docetaxel—melanoma	0.00116	0.00381	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—RAC2—melanoma	0.00115	0.00174	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Docetaxel—melanoma	0.00115	0.00378	CcSEcCtD
Prilocaine—Oedema—Docetaxel—melanoma	0.00115	0.00378	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL10—melanoma	0.00115	0.00173	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CDH2—melanoma	0.00114	0.00173	CbGpPWpGaD
Prilocaine—Dizziness—Temozolomide—melanoma	0.00114	0.00376	CcSEcCtD
Prilocaine—Vomiting—Carmustine—melanoma	0.00114	0.00374	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—ITGAV—melanoma	0.00114	0.00172	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—RAC2—melanoma	0.00113	0.00171	CbGpPWpGaD
Prilocaine—Nausea—Dactinomycin—melanoma	0.00113	0.00374	CcSEcCtD
Prilocaine—Shock—Docetaxel—melanoma	0.00113	0.00372	CcSEcCtD
Prilocaine—Nervous system disorder—Docetaxel—melanoma	0.00113	0.00371	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—MAP2K1—melanoma	0.00111	0.00168	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CDH2—melanoma	0.0011	0.00166	CbGpPWpGaD
Prilocaine—Vomiting—Temozolomide—melanoma	0.0011	0.00362	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—ITGAV—melanoma	0.00109	0.00165	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—MAPK3—melanoma	0.00109	0.00165	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NODAL—melanoma	0.00109	0.00164	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—ITGB1—melanoma	0.00107	0.00162	CbGpPWpGaD
Prilocaine—Hypotension—Docetaxel—melanoma	0.00107	0.00353	CcSEcCtD
Prilocaine—Nausea—Carmustine—melanoma	0.00106	0.0035	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—MAPK3—melanoma	0.00105	0.00158	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PAX6—melanoma	0.00105	0.00158	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—MAPK1—melanoma	0.00104	0.00157	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—EGFR—melanoma	0.00104	0.00157	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ITGB1—melanoma	0.00103	0.00156	CbGpPWpGaD
Prilocaine—Paraesthesia—Docetaxel—melanoma	0.00103	0.0034	CcSEcCtD
Prilocaine—Nausea—Temozolomide—melanoma	0.00103	0.00338	CcSEcCtD
Prilocaine—Somnolence—Docetaxel—melanoma	0.00102	0.00336	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—MAPK3—melanoma	0.00101	0.00153	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PAX6—melanoma	0.001	0.00152	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—MAPK1—melanoma	0.000997	0.00151	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—EGFR—melanoma	0.000997	0.00151	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ITGB1—melanoma	0.000994	0.0015	CbGpPWpGaD
Prilocaine—Pain—Docetaxel—melanoma	0.000982	0.00323	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—PAX6—melanoma	0.000969	0.00146	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000967	0.00146	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—MAPK1—melanoma	0.000961	0.00145	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—EGFR—melanoma	0.000961	0.00145	CbGpPWpGaD
Prilocaine—Feeling abnormal—Docetaxel—melanoma	0.000946	0.00312	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—ITGB3—melanoma	0.00093	0.00141	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAP2K2—melanoma	0.000909	0.00137	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RHOB—melanoma	0.000904	0.00137	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—DCC—melanoma	0.000894	0.00135	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ITGB3—melanoma	0.000894	0.00135	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAP2K2—melanoma	0.000874	0.00132	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—RAC1—melanoma	0.000862	0.0013	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ITGB3—melanoma	0.000862	0.0013	CbGpPWpGaD
Prilocaine—Hypersensitivity—Docetaxel—melanoma	0.000846	0.00279	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—ITGAV—melanoma	0.000843	0.00127	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT3—melanoma	0.000843	0.00127	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAP2K2—melanoma	0.000842	0.00127	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—RAC1—melanoma	0.000829	0.00125	CbGpPWpGaD
Prilocaine—Asthenia—Docetaxel—melanoma	0.000823	0.00271	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—ITGAV—melanoma	0.00081	0.00122	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT3—melanoma	0.00081	0.00122	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RAC2—melanoma	0.00081	0.00122	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—RAC1—melanoma	0.000799	0.00121	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KDR—melanoma	0.000791	0.0012	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ITGAV—melanoma	0.000781	0.00118	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT3—melanoma	0.000781	0.00118	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MET—melanoma	0.000774	0.00117	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CDH2—melanoma	0.000774	0.00117	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ITGAV—melanoma	0.00077	0.00116	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ITGB1—melanoma	0.000766	0.00116	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KDR—melanoma	0.00076	0.00115	CbGpPWpGaD
Prilocaine—Dizziness—Docetaxel—melanoma	0.000759	0.0025	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—MET—melanoma	0.000744	0.00112	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ITGB1—melanoma	0.000736	0.00111	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KDR—melanoma	0.000733	0.00111	CbGpPWpGaD
Prilocaine—Vomiting—Docetaxel—melanoma	0.00073	0.00241	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—MET—melanoma	0.000717	0.00108	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—MAPK3—melanoma	0.00071	0.00107	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ITGB1—melanoma	0.000709	0.00107	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ITGB1—melanoma	0.000699	0.00106	CbGpPWpGaD
Prilocaine—Nausea—Docetaxel—melanoma	0.000682	0.00225	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—PAX6—melanoma	0.000681	0.00103	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—MAPK1—melanoma	0.000676	0.00102	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—EGFR—melanoma	0.000676	0.00102	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ITGB3—melanoma	0.000664	0.001	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAP2K2—melanoma	0.000649	0.000981	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MMP2—melanoma	0.000646	0.000976	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAP2K1—melanoma	0.000645	0.000975	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ITGB3—melanoma	0.000638	0.000964	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000627	0.000948	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAP2K2—melanoma	0.000623	0.000942	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MMP2—melanoma	0.00062	0.000938	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAP2K1—melanoma	0.000619	0.000936	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—RAC1—melanoma	0.000615	0.00093	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ITGB3—melanoma	0.000615	0.000929	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ITGB3—melanoma	0.000606	0.000916	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAP2K2—melanoma	0.000601	0.000909	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—melanoma	0.0006	0.000907	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MMP2—melanoma	0.000598	0.000904	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAP2K1—melanoma	0.000597	0.000903	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAP2K2—melanoma	0.000592	0.000895	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—RAC1—melanoma	0.000591	0.000894	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000578	0.000874	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RAC1—melanoma	0.00057	0.000862	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—ERBB2—melanoma	0.000566	0.000855	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KDR—melanoma	0.000564	0.000853	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—RAC1—melanoma	0.000562	0.000849	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000561	0.000848	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MET—melanoma	0.000552	0.000835	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CDK4—melanoma	0.000552	0.000835	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ITGAV—melanoma	0.000549	0.00083	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT3—melanoma	0.000549	0.00083	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ERBB2—melanoma	0.000544	0.000822	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KDR—melanoma	0.000542	0.00082	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NOTCH1—melanoma	0.000532	0.000804	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CDK4—melanoma	0.000531	0.000802	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MET—melanoma	0.000531	0.000802	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ERBB2—melanoma	0.000524	0.000792	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KDR—melanoma	0.000523	0.00079	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KDR—melanoma	0.000515	0.000779	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MET—melanoma	0.000512	0.000773	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CDK4—melanoma	0.000512	0.000773	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NOTCH1—melanoma	0.000511	0.000772	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000509	0.00077	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MET—melanoma	0.000504	0.000762	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PPARG—melanoma	0.000502	0.000758	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ITGB1—melanoma	0.000499	0.000754	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NOTCH1—melanoma	0.000493	0.000744	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MMP9—melanoma	0.000485	0.000733	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PPARG—melanoma	0.000482	0.000729	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MMP9—melanoma	0.000466	0.000705	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PPARG—melanoma	0.000465	0.000703	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MMP2—melanoma	0.000461	0.000696	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAP2K1—melanoma	0.00046	0.000695	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MMP9—melanoma	0.00045	0.000679	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP2—melanoma	0.000443	0.000669	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAP2K1—melanoma	0.000442	0.000668	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—FGF2—melanoma	0.000438	0.000661	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—TNF—melanoma	0.000436	0.00066	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—VEGFA—melanoma	0.000436	0.000659	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ITGB3—melanoma	0.000432	0.000653	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—NRAS—melanoma	0.00043	0.000651	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MMP2—melanoma	0.000427	0.000645	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAP2K1—melanoma	0.000426	0.000644	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAP2K2—melanoma	0.000423	0.000639	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MMP2—melanoma	0.00042	0.000636	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—FGF2—melanoma	0.00042	0.000636	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAP2K1—melanoma	0.00042	0.000635	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—VEGFA—melanoma	0.000419	0.000633	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—NRAS—melanoma	0.000414	0.000625	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAPK3—melanoma	0.000412	0.000623	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—FGF2—melanoma	0.000405	0.000613	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ERBB2—melanoma	0.000404	0.00061	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—VEGFA—melanoma	0.000404	0.00061	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RAC1—melanoma	0.000401	0.000606	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—NRAS—melanoma	0.000399	0.000603	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAPK3—melanoma	0.000396	0.000599	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAPK1—melanoma	0.000392	0.000593	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—EGFR—melanoma	0.000392	0.000593	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ERBB2—melanoma	0.000388	0.000586	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAPK3—melanoma	0.000382	0.000577	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAPK1—melanoma	0.000377	0.00057	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—EGFR—melanoma	0.000377	0.000569	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ERBB2—melanoma	0.000374	0.000565	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KRAS—melanoma	0.00037	0.00056	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ERBB2—melanoma	0.000368	0.000557	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KDR—melanoma	0.000368	0.000556	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAPK1—melanoma	0.000363	0.000549	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—EGFR—melanoma	0.000363	0.000549	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MET—melanoma	0.00036	0.000544	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CDK4—melanoma	0.00036	0.000544	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KRAS—melanoma	0.000356	0.000538	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CTNNB1—melanoma	0.000353	0.000534	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6—melanoma	0.000352	0.000532	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NOTCH1—melanoma	0.000346	0.000523	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MMP9—melanoma	0.000346	0.000523	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KRAS—melanoma	0.000343	0.000519	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NFKB1—melanoma	0.000343	0.000518	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CTNNB1—melanoma	0.000339	0.000513	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP9—melanoma	0.000333	0.000503	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NFKB1—melanoma	0.000329	0.000498	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CTNNB1—melanoma	0.000327	0.000495	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PPARG—melanoma	0.000327	0.000494	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MMP9—melanoma	0.000321	0.000485	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NFKB1—melanoma	0.000317	0.00048	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MMP9—melanoma	0.000316	0.000478	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—HRAS—melanoma	0.000315	0.000476	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VEGFA—melanoma	0.000311	0.00047	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—STAT3—melanoma	0.000308	0.000465	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NRAS—melanoma	0.000307	0.000464	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—HRAS—melanoma	0.000303	0.000457	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6—melanoma	0.000301	0.000456	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP2—melanoma	0.0003	0.000454	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAP2K1—melanoma	0.0003	0.000453	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—VEGFA—melanoma	0.000299	0.000452	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—STAT3—melanoma	0.000296	0.000447	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NRAS—melanoma	0.000295	0.000446	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAPK3—melanoma	0.000294	0.000445	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—HRAS—melanoma	0.000292	0.000441	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—IL6—melanoma	0.00029	0.000438	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—VEGFA—melanoma	0.000288	0.000435	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—STAT3—melanoma	0.000285	0.000431	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—FGF2—melanoma	0.000285	0.000431	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NRAS—melanoma	0.000285	0.00043	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VEGFA—melanoma	0.000284	0.000429	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAPK3—melanoma	0.000283	0.000427	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—NRAS—melanoma	0.00028	0.000424	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAPK1—melanoma	0.00028	0.000423	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—EGFR—melanoma	0.00028	0.000423	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—IL6—melanoma	0.000279	0.000422	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAPK3—melanoma	0.000273	0.000412	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAPK1—melanoma	0.000269	0.000406	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EGFR—melanoma	0.000269	0.000406	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAPK3—melanoma	0.000268	0.000406	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—TNF—melanoma	0.000266	0.000403	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KRAS—melanoma	0.000264	0.0004	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ERBB2—melanoma	0.000263	0.000397	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAPK1—melanoma	0.000259	0.000392	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EGFR—melanoma	0.000259	0.000392	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—TNF—melanoma	0.000256	0.000387	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAPK1—melanoma	0.000255	0.000386	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—EGFR—melanoma	0.000255	0.000386	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KRAS—melanoma	0.000254	0.000384	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—TNF—melanoma	0.000247	0.000373	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KRAS—melanoma	0.000245	0.00037	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KRAS—melanoma	0.000241	0.000365	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CTNNB1—melanoma	0.00023	0.000348	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP9—melanoma	0.000226	0.000341	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HRAS—melanoma	0.000225	0.00034	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NFKB1—melanoma	0.000223	0.000337	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HRAS—melanoma	0.000216	0.000326	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IL6—melanoma	0.000215	0.000325	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HRAS—melanoma	0.000208	0.000315	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—IL6—melanoma	0.000207	0.000312	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—HRAS—melanoma	0.000205	0.00031	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VEGFA—melanoma	0.000203	0.000306	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—STAT3—melanoma	0.000201	0.000303	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NRAS—melanoma	0.0002	0.000302	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6—melanoma	0.000199	0.000301	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT1—melanoma	0.000198	0.0003	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6—melanoma	0.000196	0.000297	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAPK3—melanoma	0.000192	0.00029	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT1—melanoma	0.000191	0.000288	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT1—melanoma	0.000184	0.000278	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAPK1—melanoma	0.000182	0.000276	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EGFR—melanoma	0.000182	0.000275	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TNF—melanoma	0.000174	0.000262	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KRAS—melanoma	0.000172	0.00026	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HRAS—melanoma	0.000146	0.000221	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6—melanoma	0.00014	0.000212	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT1—melanoma	0.000129	0.000195	CbGpPWpGaD
